ASA’s recent ruling on a medicinal claim

ASA’s recent ruling on a medicinal claim

An ad was recently ruled as unacceptable by the ASA. This ad featured many medicinal claims which users may understand to be a solution for problems such as insomnia and menopause. The ASA has taken the advertisement down and advised that future products must not...
ASA’s recent ruling on a medicinal claim

OPSS Calls for interest on several ingredients

The Office for Product Safety and Standards (OPSS) has called for a call for interest for many ingredients suspected to have endocrine disrupting properties. A call for interest was launched on the 9th of October 2025, as some of the ingredients below are suspected to...
ASA’s recent ruling on a medicinal claim

GB Mandatory Classification and Labelling Update

The World Trade Organisation (WTO) was notified of the updated ‘making available’ date by the Health and Safety Executive (HSE). A new update is presented in the GB Mandatory CLP. The Health and Safety Executive (HSE) had notified the World Trade Organisation (WTO)...
ASA’s recent ruling on a medicinal claim

Tea tree oil – The HSE’s final opinion

Substance: Tea Tree Oil The HSE published it’s final opinion on the proposed mandatory classification of Tea Tree Oil which contradicts both the EU RAC’s position. new studies could contribute to changes in hazard identification On August 8, 2025, the Health and...